Among the six upregulated genes in ATC components, RIPK2 (receptor-interacting protein kinase 2) has been reported to be highly expressed in some cancer types, such as bladder urothelial, breast invasive, and thyroid carcinomas [18–20]. Here, RIPK2 is linked to cancer.